US FDA Looks To Assure Advisory Committees' Subject Expertise With More Temporary Members
Expect More Temporary Members Voting In US FDA Advisory Committees
Executive Summary
Reform efforts in CDER include ensuring expertise is specific to the issues being discussed, which may mean more temporary voting members on advisory committees.
You may also be interested in...
Docket Open For OTC Oral Phenylephrine GRASE Meeting, And So Is NDAC Consumer Member Seat
Docket opened for 11-12 September NDAC meeting to consider oral phenylephrine GRASE data available since the agency last examined the ingredient. FDA also accepting nominations for individuals or representatives of consumer organizations for vacancies in voting or non-voting seats across its drug and medical technology advisory committees.
US FDA Advisory Committee Formats Can Spur Unhealthy Dynamics – Califf
FDA commissioner is thinking about how advisory panel interactions might improperly influence meeting outcomes as the agency undertakes a 'stem to stern' review of the process.
US FDA Advisory Committee Formats Can Spur Unhealthy Dynamics – Califf
FDA commissioner is thinking about how advisory panel interactions might improperly influence meeting outcomes as the agency undertakes a 'stem to stern' review of the process.